Gee how many more products will Elite have on the market in the next 5 years. The company would be able to be cash flow positive now if they scrapped their R&D expenses which would be ludicrous with their ADT pipeline. Launch SequestOx and the company becomes CFP on this product plus the existing generics alone.
But hey they have 6 more generics the FDA has approved already waiting for site approval.
Not that hard to see that 12.8 million in cash is only going to continue to get bigger.
Market Data 
Markets 
AI
